Monoclonal antibodies, there are some news. “We are about to realize a study on the use of intra-intramuscular monoclonal antibodies, “he tells Adnkronos Salute the virologist of the University of Milan Fabrizio Pregliasco. They will be, he explains, “to be compared to the intravenous use, already authorized, to see if this administration can be adopted. If our Ethics Committee gives the ok, a study will start, which is multicentre, and for which we hope to succeed immediately. to recruit at least a dozen patients. This route of administration could exemplify things “, also in view of home care with these medicines.
In particular, then, in the new Protocol on home care for Covid patients, drawn up by the Prevention Department of the Ministry of Health, and expected shortly, “is underlined the possibility of initiating patients with recent onset Covid and with mild to moderate symptoms, to monoclonal antibody therapy“. According to Pregliasco” it is important to strengthen the hospital-territory proximity, therefore the doctor’s alert who must always maintain positive contact with the patient, in order to administer them as early as possible in a protected environment. I think it is an element to be evaluated to confirm results that seem interesting “.
The Indian variant of Sars-Cov-2 of which a case was reported today in Switzerland, “some others had already been identified in Italy”, for the first time in Florence on 10 March, requires for now “maximum attention and an ability to identify it in order to understand and deepen its characteristics, that is, how much more contagious it can be and if it escapes a little from vaccines “. “Unfortunately – he observes – the variants will keep us company even later, especially when the virus will have difficulty with vaccinations, thus continuing to experiment with mutations. And for this we will need to make recalls with vaccines updated according to the variants”, he concludes.